CIM, LLC Buys 3, Sells 2 in 2nd Quarter

CIM, LLC recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

30 S. PEARL STREET, 9TH FLOOR ALBANY, NY 12207

As of the latest 13F report, the guru’s equity portfolio contained 147 stocks valued at a total of $482.00Mil. The top holdings were AAPL(4.04%), PGR(4.00%), and NVO(3.73%).

According to GuruFocus data, these were CIM, LLC’s top five trades of the quarter.

ISHARES TRUST


CIM, LLC reduced their investment in NAS:MBB by 95,898 shares. The trade had a 1.77% impact on the equity portfolio. During the quarter, the stock traded for an average price of $97.83.

On 07/11/2022, ISHARES TRUST traded for a price of $97.47 per share and a market cap of $21.37Bil. The stock has returned -9.64% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

The Walt Disney Co


The guru sold out of their 59,198-share investment in NYSE:DIS. Previously, the stock had a 1.44% weight in the equity portfolio. Shares traded for an average price of $111.41 during the quarter.

On 07/11/2022, The Walt Disney Co traded for a price of $93.64 per share and a market cap of $170.56Bil. The stock has returned -44.53% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, The Walt Disney Co has a price-earnings ratio of 65.29, a price-book ratio of 1.86, a EV-to-Ebitda ratio of 20.01 and a price-sales ratio of 2.25.

The price-to-GF Value ratio is 0.60, earning the stock a GF Value rank of 8.

UnitedHealth Group Inc


During the quarter, CIM, LLC bought 12,028 shares of NYSE:UNH for a total holding of 33,423. The trade had a 1.3% impact on the equity portfolio. During the quarter, the stock traded for an average price of $502.32.

On 07/11/2022, UnitedHealth Group Inc traded for a price of $516.95 per share and a market cap of $484.99Bil. The stock has returned 27.97% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 9 out of 10.

In terms of valuation, UnitedHealth Group Inc has a price-earnings ratio of 28.02, a price-book ratio of 6.62, a price-earnings-to-growth (PEG) ratio of 2.12, a EV-to-Ebitda ratio of 18.46 and a price-sales ratio of 1.66.

The price-to-GF Value ratio is 1.27, earning the stock a GF Value rank of 1.

PIMCO Enhanced Short Maturity Active Exchange-Traded Fund


The guru established a new position worth 39,959 shares in ARCA:MINT, giving the stock a 0.82% weight in the equity portfolio. Shares traded for an average price of $99.52 during the quarter.

On 07/11/2022, PIMCO Enhanced Short Maturity Active Exchange-Traded Fund traded for a price of $99.04 per share and a market cap of $11.52Bil. The stock has returned -2.37% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

SPDR Bloomberg 1-3 Month T-Bill ETF


During the quarter, CIM, LLC bought 41,798 shares of ARCA:BIL for a total holding of 44,881. The trade had a 0.79% impact on the equity portfolio. During the quarter, the stock traded for an average price of $91.37.

On 07/11/2022, SPDR Bloomberg 1-3 Month T-Bill ETF traded for a price of $91.43 per share and a market cap of $20.80Bil. The stock has returned 0.07% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.